ABL Bio

Seongnam, South Korea

ABL Bio is a biotech research company that focuses on the development of therapeutic drugs for immuno-oncology diseases.

$3.0M raised

Sep 2023

Venture - Series Unknown

Top Investors

Korea Investment PartnersIMM InvestmentDSC InvestmentDS Asset ManagementQUAD Investment Management

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has ABL Bio raised?

ABL Bio has raised $3.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2023.

Who are ABL Bio's investors?

ABL Bio's investors include Korea Investment Partners, IMM Investment, DSC Investment, DS Asset Management, QUAD Investment Management.

Where is ABL Bio headquartered?

ABL Bio is headquartered in Seongnam, South Korea.

What does ABL Bio do?

ABL Bio is a biotech research company that focuses on the development of therapeutic drugs for immuno-oncology diseases.

What stage is ABL Bio at?

ABL Bio is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 7, 2023.

MLA

"ABL Bio — Funding & Investors." VCBacked, September 7, 2023, https://www.vcbacked.co/company/abl-bio. Accessed June 3, 2026.

APA

VCBacked. (2023). ABL Bio — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/abl-bio

Wikipedia (cite web)

{{cite web |title=ABL Bio — Funding & Investors |url=https://www.vcbacked.co/company/abl-bio |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 7, 2023.